GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

Phyton Acquires Glyco-Engineering Technique

  • Phyton Biotech acquired Dow Chemical’s technology and intellectual property platform for the engineering of glycosylation in pharmaceutical protein products.

    This transaction will be enhanced through a research collaboration with the Dutch research institute Plant Research International, part of Wageningen University & Research Centre and one of the innovators of the technology platform, according to Phyton.

    The Dow agreement coincides with the installation of a second 75,000-liter bioreactor at Phyton’s German cell fermentation facility.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?